Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Kovsie students’ artworks selected for Absa L’Atelier Awards 2013
2013-03-24

 

Learners from Ferrum High School in Newcastle, KwaZulu-Natal, admiring the artworks at the Centenary gallery.
Photo: Linda Fekisi
24 March 2013

Four artworks by Kovsie students have been selected for the 2013 Absa L’Atelier Awards. The artworks will form part of the national Absa L’Atelier exhibition later this year, which will be held at the Absa Gallery in Johannesburg.

Mandi Bezuidenhout, Louis Kruger and Johannes Botma, all master’s students in Fine Arts, have been selected as finalists for the central region of the prestigious competition.Two artworks of Louis, and one each of Mandi and Johannes, have been selected for the awards. Pauline Gutter, a former Kovsie student, has also been selected as finalist for the central region.

The Absa L’Atelier is South Africa’s most prestigious art competition and is held annually for artists between the ages of 21 and 35. This award not only ensures recognition for South Africa’s emerging artists, but also affords them the opportunity to develop their talents abroad. The winner of last year’s competition, Elrie Joubert, graduated with a master’s in Fine Arts from the UFS in 2010.

Four prizes are available in 2013’s competition. The first prize consists of R125 000 and a residency at the Cité Internationale des Arts in Paris. An Apersand Foundation Residency in New York City and a Sylt Foundation Residency on the Island of Sylt, Germany, will be granted through two merit awards. The most promising artist will receive the Gerard Sekoto Award of R80 000, as well as a residency at the Cité Internationale des Arts in Paris.

The Absa L’Atelier art competition is run in conjunction with the South African National Association for the Visual Arts (SANAVA).

An exhibition of artworks from the central region is currently on display at the Centenary Gallery, upstairs in the Centenary Complex, until 28 March 2013. The gallery will be open on 20, 25, 26, 27, and 28 March from 10:00 to 15:00.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept